BRIEF-Regeneron says Q4 U.S. Eylea sales about $400 mln

Tue Jan 14, 2014 10:58am EST

Jan 14 (Reuters) - Regeneron Pharmaceuticals Inc : * Says Q4 U.S. Eylea sales about $400 million * CEO says 2013 U.S. Eylea sales about $1.4 billion * CEO says quite a bit of room for Eylea growth * Says Sanofi to spend about $1 billion on Regeneron pipeline in 2014

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.